Viewing Study NCT05722275



Ignite Creation Date: 2024-05-06 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05722275
Status: RECRUITING
Last Update Posted: 2023-02-14
First Post: 2022-12-30

Brief Title: Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Sponsor: Chinese Academy of Sciences
Organization: Chinese Academy of Sciences

Study Overview

Official Title: Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics a Multi-center Prospective Study
Status: RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Peritoneal metastasis of gastric cancer is difficult to be detected in time thus delaying treatment Based on the conventional CT images of gastric cancer this study plans to develop improve and validate an intelligent analysis system based on radiomics By extracting and combining the radiomics features related to peritoneal metastasis of gastric cancer the intelligent analysis system could predict the risk of peritoneal metastasis and provide personalized decision suggestions for the treatment of gastric cancer
Detailed Description: Peritoneal metastasis of gastric cancer is difficult to be detected in time thus delaying treatment Based on the conventional CT images of gastric cancer this study plans to develop improve and validate an intelligent analysis system based on radiomics By extracting and combining the radiomics features related to peritoneal metastasis of gastric cancer the intelligent analysis system could predict the risk of peritoneal metastasis and provide personalized decision suggestions for the treatment of gastric cancer

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None